Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-like protein family member 11B (RASL11B) is a small cytosolic GTPase belonging to the Ras superfamily. Unlike many Ras-related proteins, RASL11B lacks typical prenylation signals and is predominantly localized in the cytoplasm rather than at membranes. It is ubiquitously expressed, with highest levels in placenta and macrophages, and is implicated in multiple biological processes, including the negative regulation of cell proliferation and migration, promotion of cell cycle arrest and apoptosis, and chondrogenic differentiation of stem cells. Functionally, RASL11B acts as a modulator of the TGF-β signaling pathway and is involved in developmental, inflammatory, and vascular pathophysiologies. Pathologically, RASL11B is downregulated in clear cell renal cell carcinoma (suggesting tumor-suppressive properties), upregulated in neuroblastoma (as a putative biomarker), and identified as a key factor in chondrogenic differentiation (possible target for cartilage repair). Its precise molecular interactors and mechanisms of action in human disease are the subject of ongoing research[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-like protein family member 11B (RASL11B).